Supplement reference
TUDCA
A source-linked reference on TUDCA, evidence, safety and product identity. Sources checked 6 September 2026.
Source and review status
Published sources checked
Sources checked on: 6 September 2026
Qualified clinical review: Pending. This page has not been clinically reviewed.
About this source check
AI-assisted editorial source checking covers the cited material and its stated limits. It is not a systematic review, verification of a supplied product, or clinical sign-off.
Editorial role: InfoAddict. Last material change: 6 September 2026. Next source review: 6 March 2027.
Ingredient and preparation
TUDCA is tauroursodeoxycholic acid, a bile-acid derivative sold in supplement products.
Sources: National Library of Medicine, PubMed
Evidence and limits
The cited 24-week trial compared TUDCA with UDCA in 199 Chinese patients with primary biliary cholangitis. It cannot establish benefits for “detox”, general liver health or people without that condition.
Sources: National Library of Medicine, PubMed
Safety and a useful record
Persistent abdominal symptoms, jaundice or abnormal liver tests warrant clinical assessment rather than self-treatment with a supplement. Medicine context should be reviewed.
Sources: National Library of Medicine, PubMed, National Center for Complementary and Integrative Health
Record the exact product, symptoms, tests and other medicines for a clinician conversation.
Sources: National Center for Complementary and Integrative Health
Published sources
- A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis
National Library of Medicine, PubMed. Published 2016; accessed 6 September 2026.
Supports: A 199-participant, 24-week trial in Chinese patients with primary biliary cholangitis, not a wellness or general liver product study.
- Safe Use of Complementary Health Products and Practices
National Center for Complementary and Integrative Health. Current NCCIH reference; accessed 6 September 2026.
Supports: General safety, interaction and contamination context. It does not establish ingredient-specific benefit.
Change history
| Date | Change | Clinical-review status |
|---|---|---|
| 6 September 2026 | Source-linked reference published | Pending |
Keep a private record
UpgradeYourself lets you keep private records of routines and observations you choose to discuss with a qualified health professional. This reference does not recommend starting, stopping or changing an item.